Studies by Mao et al. (2021) and Fu et al. (2021) suggested that silencing of EIF4A3 can significantly inhibit prostate cancer cell proliferation, migration, invasion, and epithelial-mesenchymal transition. Here, EIF4A3 is linked to prostate cancer.